Get startedLog in
    Picture of POINT Biopharma Global logo

    PNT — POINT Biopharma Global News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMid Cap
    All News

    Brief: Point Biopharma Global Inc Reports Quarterly Net Loss Per Share Of $0.26

    Picture of POINT Biopharma Global logoPOINT Biopharma Global
    14/11/2022 13:38
    Nov 14 (Reuters) - Point Biopharma Global Inc  PNT.O :
    * POINT BIOPHARMA REPORTS THIRD QUARTER 2022 FINANCIAL
RESULTS AND
ANNOUNCES STRATEGIC COLLABORATION AND EXCLUSIVE LICENSE
AGREEMENTS WITH LANTHEUS HOLDINGS
    * QTRLY NET LOSS PER SHARE $0.26
    * Q3 EARNINGS PER SHARE VIEW $-0.28 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNXbPQxYh 
Further company coverage:  PNT.O 
 ((Reuters.Briefs@thomsonreuters.com;;))

    Recent news on POINT Biopharma Global

    See all news